Fetal striatal grafting slows motor and cognitive decline of Huntington's disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 85, Issue 9, 2014, Pages 974-981

  Paganini, Marco ^a,b   Biggeri, Annibale ^a,c   Romoli, Anna Maria ^a   Mechi, Claudia ^a   Ghelli, Elena ^a   Berti, Valentina ^d   Pradella, Silvia ^a   Bucciantini, Sandra ^b   Catelan, Dolores ^a,c   Saccardi, Riccardo ^b   Lombardini, Letizia ^b,e   Mascalchi, Mario ^d   Massacesi, Luca ^a,b   Porfirio, Berardino ^b,d   Di Lorenzo, Nicola ^a   Vannelli, Gabriella Barbara ^d   Gallina, Pasquale ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c Molecular and Nutritional Epidemiology Unit Cancer   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

^e National Center for Transplantation   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CEFOTAXIME; CYCLOSPORIN A; DIAZEPAM; DOPAMINE 2 RECEPTOR; FLUCONAZOLE; FLUORODEOXYGLUCOSE F 18; HLA ANTIBODY; IODOBENZAMIDE I 123; METHYLPREDNISOLONE; PIMOZIDE; SERTRALINE; TEICOPLANIN; TETRABENAZINE; TIAPRIDE; TRACER; UNCLASSIFIED DRUG; VALPROIC ACID;

ADULT; AGE; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BRAIN METABOLISM; CAG REPEAT; CLINICAL ARTICLE; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE DURATION; DISEASE SEVERITY; DRUG BLOOD LEVEL; EDUCATIONAL STATUS; FEMALE; FETAL TISSUE TRANSPLANTATION; FETUS; FOLLOW UP; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFECTION PREVENTION; MALE; MIDDLE AGED; MOTOR PERFORMANCE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; ONSET AGE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR DENSITY; SEX DIFFERENCE; SINGLE DRUG DOSE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THERAPY EFFECT; TREATMENT DURATION; UNIFIED HUNTINGTON DISEASE RATING SCALE; YOUNG ADULT;

HUNTINGTON'S; STEREOTAXIC SURGERY;

ADULT; BRAIN TISSUE TRANSPLANTATION; CEREBRAL CORTEX; CORPUS STRIATUM; FEMALE; FETAL TISSUE TRANSPLANTATION; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; FUNCTIONAL NEUROIMAGING; HUMANS; HUNTINGTON DISEASE; IODOBENZENES; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, DOPAMINE D2; TREATMENT OUTCOME;

EID: 84905474538     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2013-306533     Document Type: Article

References (34)

1. Wijeyekoon R, Barker RA. The current status of neural grafting in the treatment of Huntington's Disease. A review. Front Integr Neurosci 2011;5:78.
2. Peschanski M, Cesaro P, Hantraye P. Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease. Neuroscience 1995;68:273-85.
3. Kopyov OV, Jacques S, Lieberman A, et al. Safety of intrastriatal neurotransplantation for Huntington's disease patients. Exp Neurol 1998;149:97-108. (Pubitemid 28091019)
4. Bachoud-Lévi AC, Bourdet C, Brugières P, et al. Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington' s disease. Exp Neurol 2000;161:194-202. (Pubitemid 30136541)
5. Hauser RA, Furtado S, Cimino CR, et al. Bilateral human fetal striatal transplantation in Huntington's disease. Neurology 2002;58:687-95. (Pubitemid 34211545)
6. Rosser AE, Barker RA, Harrower T, et al. Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475. J Neurol Neurosurg Psychiatry 2002;73:678-85. (Pubitemid 35448852)
7. Gallina P, Paganini M, Di Rita A, et al. Human fetal striatal transplantation in Huntington's disease: a refinement of the stereotactic procedure. Stereotact Funct Neurosurg 2008;86:308-13.
8. Barker RA, Mason SL, Harrower TB, et al. The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease. J Neurol Neurosurg Psychiatry 2013; 84:657-65.
9. Bachoud-Lévi AC, Gaura V, Brugières P, et al. Effect of foetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study. Lancet Neurol 2006;5:303-9.
10. Reuter I, Tai YF, Pavese N, et al. Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease. J Neurol Neurosurg Psychiatry 2008;79:948-51.
11. Cicchetti F, Soulet D, Freeman TB. Neuronal degeneration in striatal transplants and Huntington's disease: potential mechanisms and clinical implications. Brain 2011;134:641-52.
12. Bachoud-Lévi AC, Rémy P, Nguyen JP, et al. Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet 2000;356: 1975-9.
13. Gallina P, Paganini M, Lombardini L, et al. Development of human striatal anlagen after transplantation in a patient with Huntington's disease. Exp Neurol 2008;213:241-4.
14. Gallina P, Paganini M, Lombardini L, et al. Human striatal neuroblasts develop and build a striatal-like structure into the brain of Huntington's disease patients after transplantation. Exp Neurol 2010;222:30-41.
15. Krystkowiak P, Gaura V, Labalette M, et al. Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with Huntington's disease. PLoS ONE 2007;2:e166.
16. Krebs SS, Trippel M, Prokop T, et al. Immune response after striatal engraftment of fetal neuronal cells in patients with Huntington' s disease: consequences for cerebral transplantation programs. Clin Exp Neuroimmunol 2011;2:25-32.
17. Bachoud-Lévi AC. Neural grafts in Huntington' s disease: viability after 10 years. Lancet Neurol 2009;8:979-81.
18. Keene CD, Chang RC, Leverenz JB, et al. A patient with Huntington's disease and long-surviving fetal neural transplants that developed mass lesions. Acta Neuropathol 2009;117:329-38.
19. Orth M, Handley OJ, Schwenke C, et al. Observing Huntington's disease: the European Huntington's Disease Network' s REGISTRY. PLoS Curr Huntington Dis 2010 Sep 28 [last modified: 4 April 2012]. Edition 1. doi:10.1371/currents. RRN1184
20. Huntington's Study Group. Unified Huntington's disease rating scale: reliability and consistency. Mov Disord 1996;11:136-42.
21. Quinn N, Brown R, Craufurd D, et al. Core Assessment Program for intracerebral transplantation in Huntington's disease (CAPIT-HD). Mov Disord 1996;11:143-50. (Pubitemid 26082780)
22. Skrondal A, Rabe-Hesketh S. Generalized latent variable modeling: multilevel, longitudinal, and structural equation models. Boca Raton, FL: Chapman & Hall/CRC Press, 2004.
23. Penney JB Jr, Vonsattel JP, MacDonald ME, et al. CAG repeat number governs the development rate of pathology in Huntington's disease. Ann Neurol 1997;41:689-92. (Pubitemid 27212666)
24. Byth K, Cox DR. On the relation between initial value and slope. Biostatistics 2005;6:395-403. (Pubitemid 41442758)
25. Tu Y-K, Gilthorpe MS. Revisiting the relation between change and initial value: a review and evaluation. Statist Med 2007;26:443-57. (Pubitemid 46099410)
26. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 1995;57:289-300.
27. Magee L. R-squared measures based on Wald and likelihood ratio joint significance tests. Am Statist 1990;44:250-3.
28. Efron B, Tibshirani RJ. An introduction to the Bootstrap. New York, NY: Chapman & Hall/CRC, 1993.
29. Turner DA, Kearney W. Scientific and ethical concerns in neural fetal tissue transplantation. Neurosurg 1993;33:1031-7. (Pubitemid 23358398)
30. McRae C, Cherin E, Yamazaki TG, et al. Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial. Arch Gen Psychiatry 2004;61:412-20. (Pubitemid 38451551)
31. Bonelli RM, Hofmann P. A systematic review of the treatment studies in Huntington's disease since 1990. Expert Opin Pharmacother 2007;8:141-53. (Pubitemid 46206617)
32. Kremer B, Clark CM, Almqvist EW, et al. Influence of lamotrigine on progression of early Huntington disease: a randomized clinical trial. Neurology 1999;53:1000-11. (Pubitemid 29442116)
33. Gaura V, Bachoud-Lévi AC, Ribeiro M, et al. Striatal neural grafting improves cortical metabolism in Huntington 's disease patients. Brain 2004;127:65-72. (Pubitemid 38055346)
34. Ciarmiello A, Cannella M, Lastoria S, et al. Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease. J Nucl Med 2006;47:215-22. (Pubitemid 46780885)